Skip to main content

Advertisement

Log in

Expression of CD34 and CD105 as markers for angiogenesis in oral vascular malformations and pyogenic granulomas

  • Head and Neck
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

The objective of this study was to assess angiogenic activity by analyzing anti-CD105 and anti-CD34 immunostaining in 20 cases of vascular malformations (VMs) and 20 cases of oral pyogenic granulomas (OPG). In addition, the usefulness of these markers for the differential diagnosis of these two oral tumors was evaluated. The results showed no significant difference in mean microvessel count between the anti-CD105 (P = 0.803) and anti-CD34 (P = 0.279) antibody. The mean number of vessels was 18.75 and 59.72 for oral VMs immunostained with anti-CD105 and anti-CD34 antibody, respectively, whereas in OPG the mean number was 20.22 and 48.09, respectively. CD34 was found to be more effective than CD105 in identifying blood vessels. However, the anti-CD105 antibody seems to be more related to vascular neoformation. Overall, this study supports the role of angiogenic factors in the etiopathogenesis of oral VMs and PG, but the results showed that quantification of angiogenesis cannot be used as a marker for the differential diagnosis of these two types of lesions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Soares AB, Juliano PB, Araujo VC, Metze K, Altemani A (2007) Angiogenic switch during tumor progression of carcinoma ex-pleomorphic adenoma. Virchows Arch 451(1):65–71

    Article  PubMed  CAS  Google Scholar 

  2. Netto GC, Bleil CB, Hilbig A, Coutinho LM (2008) Immunohistochemical evaluation of the microvascular density through the expression of TGF-β (CD105/endoglin) and CD34 receptors and expression of the vascular endothelial growth factor (VEGF) in oligodendrogliomas. Neuropathology 28(1):17–23

    Article  PubMed  Google Scholar 

  3. Freitas TM, Miguel MC, Silveira EJ, Freitas RA, Galvão HC (2005) Assessment of angiogenic markers in oral hemangiomas and pyogenic granulomas. Exp Mol Pathol 79(1):79–85

    Article  PubMed  CAS  Google Scholar 

  4. Llorca O, Trujillo A, Blanco FJ, Bernabeu C (2007) Structural model of human endoglin, a transmembrane receptor responsible for hereditary hemorrhagic telangiectasia. J Mol Biol 365(3):694–705

    Article  PubMed  CAS  Google Scholar 

  5. Heimburg S, Oehler MK, Papadopoulos T, Caffier H, Kristen P, Dietl J (1999) Prognostic relevance of the endothelial marker CD34 in ovarian cancer. Anticancer Res 19(4A):2527–2529

    PubMed  CAS  Google Scholar 

  6. Buckmiller LM, Richter GT, Suen JY (2010) Diagnosis and management of hemangiomas and vascular malformations of the head and neck. Oral Dis 16:405–418

    Article  PubMed  CAS  Google Scholar 

  7. Maeda K, Chung YS, Takatsuka S, Ogawa Y, Onoda N, Sawada T, Kato Y, Nitta A, Arimoto Y, Kondo Y (1995) Tumor angiogenesis and tumour cell proliferation as prognostic indicator in gastric carcinoma. Br J Cancer 72(2):319–323

    Article  PubMed  CAS  Google Scholar 

  8. Wakulich C, Jackson-Boeters L, Daley TD, Wysocki GP (2002) Immunohistochemical localization of growth factors fibroblast growth factor-1 and fibroblast growth factor-2 and receptors fibroblast growth factor receptor-2 and fibroblast growth factor receptor-3 in normal oral epithelium, epithelial dysplasias, and squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 93(5):573–579

    Article  PubMed  Google Scholar 

  9. Guttman D, Stern Y, Shpitzer T, Ulanovski D, Druzd T, Feinmesser R (2004) Expression of MMP-9, TIMP-1, CD34 and factor-8 as prognostic markers for squamous cell carcinoma of the tongue. Oral Oncol 40(8):798–803

    Article  PubMed  CAS  Google Scholar 

  10. Martone T, Rosso P, Albera R, Migliaretti G, Fraire F, Pignataro L, Pruneri G, Bellone G, Cortesina G (2005) Prognostic relevance of CD105+ microvessel density in HNSCC patient outcome. Oral Oncol 4(2):147–155

    Article  Google Scholar 

  11. Ascani G, Balercia P, Messi M, Lupi L, Goteri G, Filosa A, Stramazzotti D, Pieramici T, Rubini C (2005) Angiogenesis in oral squamous cell carcinoma. Acta Otorhinolaryngol Ital 25(1):13–17

    PubMed  CAS  Google Scholar 

  12. Nikiteas NI, Tzanakis N, Theodoropoulos G, Atsaves V, Christoni Z, Karakitsos P, Lazaris AC, Papachristodoulou A, Klonaris C, Gazouli M (2007) Vascular endothelial growth factor and endoglin (CD105) in gastric cancer. Gastric Cancer 10(1):12–17

    Article  PubMed  CAS  Google Scholar 

  13. Chuang HC, Su CY, Huang HY, Chien CY, Chen CM, Huang CC (2006) High expression of CD105 as a prognostic predictor of early tongue cancer. Laryngoscope 116(7):1175–1179

    Article  PubMed  CAS  Google Scholar 

  14. Sundine MJ, Garrett A (2007) Hemangiomas: an overview. Clin Pediatr 43(3):206–221

    Article  Google Scholar 

  15. Jafarzadeh H, Sanatkhani M, Mohtasham N (2006) Oral pyogenic granuloma: a review. J Oral Sci 48(4):167–175

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Éricka Janine Dantas da Silveira.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vasconcelos, M.G., Alves, P.M., Vasconcelos, R.G. et al. Expression of CD34 and CD105 as markers for angiogenesis in oral vascular malformations and pyogenic granulomas. Eur Arch Otorhinolaryngol 268, 1213–1217 (2011). https://doi.org/10.1007/s00405-010-1472-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-010-1472-z

Keywords

Navigation